Global Cell Cryopreservation Market Insights Forecasts to 2033

• The Global Cell Cryopreservation Market Size was Valued at USD 12.23 Billion in 2023
• The Market Size is Growing at a CAGR of 18.45% from 2023 to 2033
• The Worldwide Cell Cryopreservation Market Size is Expected to Reach USD 66.52 Billion by 2033
• Asia-Pacific is Expected to Grow the fastest during the forecast period.

 

 

Get more details on this report -

Request Free Sample PDF

 

The Cell Cryopreservation Market Size is Anticipated to Exceed USD 66.52 Billion by 2033, Growing at a CAGR of 18.45% from 2023 to 2033.

 

CELL CRYOPRESERVATION MARKET REPORT OVERVIEW

The procedure of cryopreservation keeps biological material at cryogenic temperatures in a suspended animation condition for extended periods of time, protecting the delicate cellular structure. It's a technique for keeping biological material suspended for a long time at freezing temperatures. It keeps the delicate cell structure intact. Samples of tissues, cells, organelles, and other biological structures are cryopreserved by cooling them to extremely low temperatures, such as -196 °C for liquid nitrogen preservation or -80 °C for solid CO2. The demand for cell therapies in the global market is rising as a result of the field's quick advancements in research as well as its growing application in treating a range of diseases. For cell therapy applications, maintaining cell viability during the thawing and freezing processes is crucial, and cell freezing medium plays a key role in this regard. The market is anticipated to expand as a result of various measures put in place by industry players to promote the use of cellular therapy in the management of chronic disorders. The government's increased funding of research and development presents an alluring opportunity for the growth of cell cryopreservation.

 

Report Coverage

This research report categorizes the market for the global cell cryopreservation market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global cell cryopreservation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global cell cryopreservation market.

 

DRIVING FACTORS:

The market could grow as a result of increasing demand for stem cell research.

The market for cell cryopreservation is anticipated to expand as a result of the increased interest in stem cell research. New treatments for chronic and potentially fatal diseases such as diabetes, cancer, heart problems, and neurological disorders are being treated with the use of stem cells. Because cryopreservation makes it possible to store and transfer stem cells for extended periods of time, it is essential to stem cell research. Scientists are always trying to find ways to use stem cells' special properties, such as differentiation and regeneration, to create targeted and cell-based treatments. Both public and commercial entities are contributing substantial sums of money to the advancement of stem cell research.

 

RESTRAINING FACTORS

High startup and operating costs could stop the market from expanding.

The high startup and operational costs of cell cryopreservation facilities could hinder the growth of the worldwide cell cryopreservation market. Large capital expenditures in cutting-edge cryogenic equipment, such as automated temperature measurement systems, liquid nitrogen storage tanks, and controlled-rate freezers, are necessary to set up a cell cryopreservation lab. The expenditures are further raised by ongoing operating expenditures associated with keeping cells in cryogenic temperatures and long-term storage. Thus, the growth of the cell cryopreservation market could be hampered by its expansion.

 

Market Segmentation

The cell cryopreservation market share is classified into product, application, and end-use.

 

The consumables segment accounting the largest share of the market over the forecast period.

Based on the product, cell cryopreservation is classified into cell freezing media, equipment, and consumables. The market is going to expand as a result of various factors, including a rising incidence of chronic illnesses, increased demand for biological products, and expanding demand for cryopreservation among consumers. The primary reason for this is the rising use of cryovials, cryotubes, and other consumables by consumers due to benefits like lower contamination. The broad application of cryopreservation media in many industries, such as stem cell regrowth, drug discovery, regenerative therapies, and biobanking, is anticipated to drive the quickest growth in the freezing media market.

 

Stem cells are expected to dominate the market growth during the forecast period.

Based on application, cell cryopreservation is classified into stem cells, sperm cells, and oocytes & embryonic cells. Cell cryopreservation plays a major role in stem cell applications by enabling the preservation, storage, and transportation of stem cells without causing cellular or genetic alterations. Stem cells can function as a corrective therapy by replacing diseased or damaged bodily cells. Regenerative medicine is thus centered on harnessing this potential to provide novel treatments for a range of diseases, including neurological problems, diabetes, and heart disease. Cardiovascular disease is going to become more prevalent as the aging population and sedentary lifestyles increase, which is expected to fuel the segment's growth. The cells that are expected to grow the fastest are oocytes and embryonic cells. It is anticipated that the market will expand quickly as a result of rising egg-freezing cycles, stem cell research and development, biobanking, and a spike in the need for customized medications.

 

The IVF segment is predicted to have the largest share of the market throughout the forecast period.

Based on end-use, cell cryopreservation is classified into biobanks and IVF. There is a growing need for trustworthy and efficient cryopreservation techniques to guarantee the long-term viability of frozen eggs as more women opt for egg-freezing cycles. This has fueled the growth of the cell cryopreservation industry by raising demand for advanced infrastructure & technologies.

 

Regional Segment Analysis of the Global Cell Cryopreservation Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America has the biggest share of the cell cryopreservation market throughout the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

North America led the market due to its abundance of major cryopreservation product manufacturers, developed economies, sophisticated medical infrastructure, notable players, and well-established supply chains. In addition, the biopharmaceutical industry is in a race to develop novel and effective treatments due to the rising prevalence of illnesses and the growing older population. Over the course of the forecast period, this is expected to continue generating income due to the rising demand for cell cryopreservation. To take advantage of the personnel and financial opportunities in the area, many industry firms have established their headquarters. Research institutes in North America also work together with commercial companies that offer cryopreservation solutions. New cryopreservation techniques are encouraged to be clinically translated by the supportive regulatory environment.

 

The Asia-Pacific is the fastest-growing region during the projected timeframe.

It looks that the fastest-growing regional market could be Asia Pacific. Significant advancements in life sciences skills are being made by nations like South Korea, Japan, India, and China. Investments in cryopreservation applications for regenerative medicine and biobanking are being driven by growing healthcare costs and patient volumes. Multinational organizations and local businesses are actively collaborating to update technology and executive skills. Subsidies are given by governments to encourage the commercialization of homegrown innovations.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global cell cryopreservation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Organ Recovery Systems Inc.
• Custom Biogenic Systems
• Sartorius AG
• Takara Bio Inc.
• Chart Industries, Inc.
• Biocision, LLC
• Cardinal Health, Inc.
• Helmer Scientific
• Merck KGaA
• GE Healthcare
• Lonza Group Ltd.
• STEMCELL Technologies Inc.
• BioLife Solutions, Inc.
• Cryolife, Inc
• Others

 

Key Market Developments

• In June 2023, as part of its expanding product line, BioLife Solutions, Inc., a well-known supplier of bioproduction instruments and services for gene and cell therapy, unveiled a new large-capacity controlled-rate freezer (CRF). With the addition of three new form factors, this solution meets a major customer desire for more cell therapy manufacturing capacity on tabletop freezers.

 

• In May 2023, Breyanzi, a CAR T cell therapy targeting CD19, was approved by the European Commission for use in treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), and follicular lymphoma grade 3B (FL3B) after two or more prior treatments. Bremyers Squibb is a global biopharma company. All member nations of the European Union are covered by this authority.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global cell cryopreservation market based on the below-mentioned segments: 

 

Global Cell Cryopreservation Market, By Product

• Cell Freezing Media
• Equipment
• Consumables

 

Global Cell Cryopreservation Market, By Application

• Stem Cells
• Sperm Cells
• Oocytes & Embryotic Cells

 

Global Cell Cryopreservation Market, By End-Use

• Biobanks
• IVF

 

Global Cell Cryopreservation Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa